Table 3.
Impact of COVID-19, vaccine acceptance and adverse effects of vaccination.
| Variables | Findings |
|---|---|
| Have you been infected with COVID-19? | |
| Yes | 103 (15.5) |
| Were you quarantined? | |
| Yes | 219 (32.9) |
| Have you received the COVID-19 vaccine? | |
| No | 85(12.8) |
| Rejected | 35 (5.3) |
| It was not offered to me | 50 (7.5) |
| Yes | 581 (87.2) |
| What vaccine was used as the first dose? (n = 581) | |
| AZ | 406 (61.0) |
| PB | 141 (21.2) |
| Mo | 34 (5.1) |
| Did you receive a second dose? Which one (n = 581) | |
| No | 221 (38.0) |
| Waiting | 136 (61.5) |
| It was not offered to me | 50 (22.6) |
| Rejected | 35 (15.8) |
| Yes | 445 (62.0) |
| AZ | 259 (58.2) |
| PB | 161 (36.2) |
| Mo | 25 (5.6) |
| Any adverse effects after vaccination? (n = 581) | |
| Yes | 528 (90.9) |
| Pain in the arm | 471 (81.1) |
| Tiredness | 365 (62.8) |
| Fever | 290 (49.9) |
| Headache | 274 (47.2) |
| Generalized muscle pain | 268 (46.1) |
| Shivering | 245 (42.2) |
| Inflammation of the ganglia | 47 (8.1) |
| Vomiting | 31 (5.3) |
| Would you accept a second dose? (n = 115)* | |
| Yes, even if it's a different brand | 28 (24.3) |
| Yes, but only if it's the same brand | 80 (69.6) |
| No, under no circumstances | 4 (3.5) |
| I don't know | 3 (2.6) |
Data shown as n (%).
*
percentage calculated with respect to the total number of participants who received the first AZ dose and were waiting to receive the second one. AZ, AstraZeneca-Oxford; PB, Pfizer-BioNTech; Mo, Moderna.